
Global Allergy Immunotherapies Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
According to APO Research, The global Allergy Immunotherapies market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Allergy Immunotherapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Allergy Immunotherapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Allergy Immunotherapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Allergy Immunotherapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Allergy Immunotherapies include ALK, Stallergenes and HAL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Allergy Immunotherapies, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Allergy Immunotherapies, also provides the revenue of main regions and countries. Of the upcoming market potential for Allergy Immunotherapies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Allergy Immunotherapies revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Allergy Immunotherapies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Allergy Immunotherapies revenue, projected growth trends, production technology, application and end-user industry.
Allergy Immunotherapies Segment by Company
ALK
Stallergenes
HAL
Allergy Immunotherapies Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Allergy Immunotherapies Segment by Application
Allergic Rhinitis
Allergic Asthma
Other
Allergy Immunotherapies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Allergy Immunotherapies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Allergy Immunotherapies industry.
Chapter 3: Detailed analysis of Allergy Immunotherapies companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Allergy Immunotherapiesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
According to APO Research, The global Allergy Immunotherapies market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Allergy Immunotherapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Allergy Immunotherapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Allergy Immunotherapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Allergy Immunotherapies is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Allergy Immunotherapies include ALK, Stallergenes and HAL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Allergy Immunotherapies, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Allergy Immunotherapies, also provides the revenue of main regions and countries. Of the upcoming market potential for Allergy Immunotherapies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Allergy Immunotherapies revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Allergy Immunotherapies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Allergy Immunotherapies revenue, projected growth trends, production technology, application and end-user industry.
Allergy Immunotherapies Segment by Company
ALK
Stallergenes
HAL
Allergy Immunotherapies Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Allergy Immunotherapies Segment by Application
Allergic Rhinitis
Allergic Asthma
Other
Allergy Immunotherapies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Allergy Immunotherapies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Allergy Immunotherapies industry.
Chapter 3: Detailed analysis of Allergy Immunotherapies companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Allergy Immunotherapiesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
176 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Allergy Immunotherapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
- 1.2.2 Subcutaneous Immunotherapy
- 1.2.3 Sublingual Immunotherapy
- 1.3 Market Analysis by Application
- 1.3.1 Global Allergy Immunotherapies Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
- 1.3.2 Allergic Rhinitis
- 1.3.3 Allergic Asthma
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Allergy Immunotherapies Growth Trends by Region
- 1.5.1 Global Allergy Immunotherapies Market Size by Region: 2020 VS 2024 VS 2031
- 1.5.2 Allergy Immunotherapies Market Size by Region (2020-2025)
- 1.5.3 Allergy Immunotherapies Market Size by Region (2026-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
- 2 Global Allergy Immunotherapies Market Dynamics
- 2.1 Allergy Immunotherapies Industry Trends
- 2.2 Allergy Immunotherapies Industry Drivers
- 2.3 Allergy Immunotherapies Industry Opportunities and Challenges
- 2.4 Allergy Immunotherapies Industry Restraints
- 3 Competitive Landscape by Company
- 3.1 Global Allergy Immunotherapies Revenue by Company (2020-2025)
- 3.2 Global Allergy Immunotherapies Players Revenue Ranking, 2023 VS 2024 VS 2025
- 3.3 Global Allergy Immunotherapies Key Company Head office and Area Served
- 3.4 Global Allergy Immunotherapies Company, Product Type & Application
- 3.5 Global Allergy Immunotherapies Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Allergy Immunotherapies Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Allergy Immunotherapies Players Market Share by Revenue in 2024
- 3.6.3 2024 Allergy Immunotherapies Tier 1, Tier 2, and Tier 3
- 4 Allergy Immunotherapies Market by Type
- 4.1 Global Allergy Immunotherapies Market Size by Type (2020 VS 2024 VS 2031)
- 4.2 Global Allergy Immunotherapies Market Size by Type (2020-2031)
- 4.3 Global Allergy Immunotherapies Market Size Share by Type (2020-2031)
- 5 Allergy Immunotherapies Market by Application
- 5.1 Global Allergy Immunotherapies Market Size by Application (2020 VS 2024 VS 2031)
- 5.2 Global Allergy Immunotherapies Market Size by Application (2020-2031)
- 5.3 Global Allergy Immunotherapies Market Size Share by Application (2020-2031)
- 6 Company Profiles
- 6.1 ALK
- 6.1.1 ALK Comapny Information
- 6.1.2 ALK Business Overview
- 6.1.3 ALK Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.1.4 ALK Allergy Immunotherapies Product Portfolio
- 6.1.5 ALK Recent Developments
- 6.2 Stallergenes
- 6.2.1 Stallergenes Comapny Information
- 6.2.2 Stallergenes Business Overview
- 6.2.3 Stallergenes Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.2.4 Stallergenes Allergy Immunotherapies Product Portfolio
- 6.2.5 Stallergenes Recent Developments
- 6.3 HAL
- 6.3.1 HAL Comapny Information
- 6.3.2 HAL Business Overview
- 6.3.3 HAL Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2020-2025)
- 6.3.4 HAL Allergy Immunotherapies Product Portfolio
- 6.3.5 HAL Recent Developments
- 7 North America
- 7.1 North America Allergy Immunotherapies Market Size (2020-2031)
- 7.2 North America Allergy Immunotherapies Market Size by Type
- 7.2.1 North America Allergy Immunotherapies Market Size by Type (2020-2025)
- 7.2.2 North America Allergy Immunotherapies Market Size by Type (2026-2031)
- 7.2.3 North America Allergy Immunotherapies Market Share by Type (2020-2031)
- 7.3 North America Allergy Immunotherapies Market Size by Application
- 7.3.1 North America Allergy Immunotherapies Market Size by Application (2020-2025)
- 7.3.2 North America Allergy Immunotherapies Market Size by Application (2026-2031)
- 7.3.3 North America Allergy Immunotherapies Market Share by Application (2020-2031)
- 7.4 North America Allergy Immunotherapies Market Size by Country
- 7.4.1 North America Allergy Immunotherapies Market Size by Country (2020 VS 2024 VS 2031)
- 7.4.2 North America Allergy Immunotherapies Market Size by Country (2020-2025)
- 7.4.3 North America Allergy Immunotherapies Market Size by Country (2026-2031)
- 7.4.4 North America Allergy Immunotherapies Market Share by Country (2020-2031)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
- 8 Europe
- 8.1 Europe Allergy Immunotherapies Market Size (2020-2031)
- 8.2 Europe Allergy Immunotherapies Market Size by Type
- 8.2.1 Europe Allergy Immunotherapies Market Size by Type (2020-2025)
- 8.2.2 Europe Allergy Immunotherapies Market Size by Type (2026-2031)
- 8.2.3 Europe Allergy Immunotherapies Market Share by Type (2020-2031)
- 8.3 Europe Allergy Immunotherapies Market Size by Application
- 8.3.1 Europe Allergy Immunotherapies Market Size by Application (2020-2025)
- 8.3.2 Europe Allergy Immunotherapies Market Size by Application (2026-2031)
- 8.3.3 Europe Allergy Immunotherapies Market Share by Application (2020-2031)
- 8.4 Europe Allergy Immunotherapies Market Size by Country
- 8.4.1 Europe Allergy Immunotherapies Market Size by Country (2020 VS 2024 VS 2031)
- 8.4.2 Europe Allergy Immunotherapies Market Size by Country (2020-2025)
- 8.4.3 Europe Allergy Immunotherapies Market Size by Country (2026-2031)
- 8.4.4 Europe Allergy Immunotherapies Market Share by Country (2020-2031)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
- 9 China
- 9.1 China Allergy Immunotherapies Market Size (2020-2031)
- 9.2 China Allergy Immunotherapies Market Size by Type
- 9.2.1 China Allergy Immunotherapies Market Size by Type (2020-2025)
- 9.2.2 China Allergy Immunotherapies Market Size by Type (2026-2031)
- 9.2.3 China Allergy Immunotherapies Market Share by Type (2020-2031)
- 9.3 China Allergy Immunotherapies Market Size by Application
- 9.3.1 China Allergy Immunotherapies Market Size by Application (2020-2025)
- 9.3.2 China Allergy Immunotherapies Market Size by Application (2026-2031)
- 9.3.3 China Allergy Immunotherapies Market Share by Application (2020-2031)
- 10 Asia (Excluding China)
- 10.1 Asia Allergy Immunotherapies Market Size (2020-2031)
- 10.2 Asia Allergy Immunotherapies Market Size by Type
- 10.2.1 Asia Allergy Immunotherapies Market Size by Type (2020-2025)
- 10.2.2 Asia Allergy Immunotherapies Market Size by Type (2026-2031)
- 10.2.3 Asia Allergy Immunotherapies Market Share by Type (2020-2031)
- 10.3 Asia Allergy Immunotherapies Market Size by Application
- 10.3.1 Asia Allergy Immunotherapies Market Size by Application (2020-2025)
- 10.3.2 Asia Allergy Immunotherapies Market Size by Application (2026-2031)
- 10.3.3 Asia Allergy Immunotherapies Market Share by Application (2020-2031)
- 10.4 Asia Allergy Immunotherapies Market Size by Country
- 10.4.1 Asia Allergy Immunotherapies Market Size by Country (2020 VS 2024 VS 2031)
- 10.4.2 Asia Allergy Immunotherapies Market Size by Country (2020-2025)
- 10.4.3 Asia Allergy Immunotherapies Market Size by Country (2026-2031)
- 10.4.4 Asia Allergy Immunotherapies Market Share by Country (2020-2031)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
- 11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Allergy Immunotherapies Market Size (2020-2031)
- 11.2 South America, Middle East & Africa Allergy Immunotherapies Market Size by Type
- 11.2.1 South America, Middle East & Africa Allergy Immunotherapies Market Size by Type (2020-2025)
- 11.2.2 South America, Middle East & Africa Allergy Immunotherapies Market Size by Type (2026-2031)
- 11.2.3 South America, Middle East & Africa Allergy Immunotherapies Market Share by Type (2020-2031)
- 11.3 South America, Middle East & Africa Allergy Immunotherapies Market Size by Application
- 11.3.1 South America, Middle East & Africa Allergy Immunotherapies Market Size by Application (2020-2025)
- 11.3.2 South America, Middle East & Africa Allergy Immunotherapies Market Size by Application (2026-2031)
- 11.3.3 South America, Middle East & Africa Allergy Immunotherapies Market Share by Application (2020-2031)
- 11.4 South America, Middle East & Africa Allergy Immunotherapies Market Size by Country
- 11.4.1 South America, Middle East & Africa Allergy Immunotherapies Market Size by Country (2020 VS 2024 VS 2031)
- 11.4.2 South America, Middle East & Africa Allergy Immunotherapies Market Size by Country (2020-2025)
- 11.4.3 South America, Middle East & Africa Allergy Immunotherapies Market Size by Country (2026-2031)
- 11.4.4 South America, Middle East & Africa Allergy Immunotherapies Market Share by Country (2020-2031)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
- 12 Concluding Insights
- 13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.